NCI-sponsored digital mammography trial results reported

被引:0
|
作者
不详
机构
来源
ONCOLOGY-NEW YORK | 2005年 / 19卷 / 11期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1398 / 1398
页数:1
相关论文
共 50 条
  • [31] Assessing Radiologist Performance Using Combined Digital Mammography and Breast Tomosynthesis Compared with Digital Mammography Alone: Results of a Multicenter, Multireader Trial
    Rafferty, Elizabeth A.
    Park, Jeong Mi
    Philpotts, Liane E.
    Poplack, Steven P.
    Sumkin, Jules H.
    Halpern, Elkan F.
    Niklason, Loren T.
    RADIOLOGY, 2013, 266 (01) : 104 - 113
  • [32] NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies
    Alexander M. Spence
    Mark Muzi
    Jeanne M. Link
    Finbarr O’Sullivan
    Janet F. Eary
    John M. Hoffman
    Lalitha K. Shankar
    Kenneth A. Krohn
    Molecular Imaging and Biology, 2009, 11
  • [33] Status of mammography after the digital mammography imaging screening trial: Digital versus film
    Dershaw, DD
    BREAST JOURNAL, 2006, 12 (02): : 99 - 102
  • [34] Enrollment of and toxicity in patients 70 years and older on CTEP/NCI-sponsored, single-agent phase I studies from 1980 to 2005.
    Chow, S. L.
    Lin, Y.
    LoConte, N. K.
    Royds, R. B.
    Nekrassova, T. G.
    Ivy, S. P.
    Mauer, J.
    Wilding, G.
    Stoller, R.
    Egorin, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3'-Deoxy-3'-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies
    Spence, Alexander M.
    Muzi, Mark
    Link, Jeanne M.
    O'Sullivan, Finbarr
    Eary, Janet F.
    Hoffman, John M.
    Shankar, Lalitha K.
    Krohn, Kenneth A.
    MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (05) : 343 - 355
  • [36] Pharmacokinetics of CPT-11 in glioma patients: Pooled analysis of data from 4 NCI-sponsored trials (Duke university, NABTC, NABTT, NCCTG).
    Reid, JM
    Cha, S
    Buckner, JC
    Petros, WP
    Friedman, HS
    Tourt-Uhlig, S
    Walker, A
    Kuhn, JG
    Prados, M
    Supko, JG
    Gilbert, MR
    Batchelor, TT
    Schaaf, L
    Gaylor, SK
    McGovren, JP
    Gallo, JM
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3737S - 3737S
  • [37] Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs
    Samimi, Goli
    House, Margaret
    Benante, Kelly
    Bengtson, Lisa
    Budd, Troy
    Dermody, Bridget
    DeShong, Katina
    Dyer, Valerie
    Kimler, Bruce F.
    V. Sahasrabuddhe, Vikrant
    Siminski, Suzanne
    Ford, Leslie G.
    Vilar, Eduardo
    Szabo, Eva
    CANCER PREVENTION RESEARCH, 2022, 15 (05) : 279 - 284
  • [38] Digital imaging: Digital Mammography Imaging Screening Trial Project
    M Rebner
    Breast Cancer Research, 6 (Suppl 1)
  • [39] ACR mammography accreditation program's early digital mammography results
    Butler, P.
    Yaffe, M.
    MEDICAL PHYSICS, 2006, 33 (06) : 2166 - 2166
  • [40] Digital mammography. Results of clinical studies
    Schulz-Wendtland, R
    Hermann, KP
    Bautz, W
    RADIOLOGE, 2005, 45 (03): : 255 - 263